Processa Pharmaceuticals, Inc. Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current
Processa Pharmaceuticals, Inc. (PCSA) had Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current of $77.24 thousand as of 2016-03-31, per its 10-Q filed 2017-08-07.
Discontinued › Notes
us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent · last filed 2017-09-25
- 2016-03-31: Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current $77.24K.
- 2015-12-31: Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current $70.36K.
- 2014-12-31: Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current $63.21K.
| Period end | Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current |
|---|---|
| 2016-03-31 | $77.24K 10-Q · filed 2017-08-07 |
| 2015-12-31 | $70.36K 10-K · filed 2017-09-25 |
| 2014-12-31 | $63.21K 10-K · filed 2017-06-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |